Article Figures & Tables
Figures
- Fig. 1.
The levels of miR-96-5p in OSCC tissues and cell lines. (A) Quantitative RT-PCR analysis of miR-96-5p level in OSCC tissues and adjacent normal tissues (n=40). Transcript levels were normalized to U6 level. (B) Relative miR-96-5p level analyzed via quantitative RT-PCR in five OSCC cell lines normalized to U6 (n=6). All data are presented as means±s.e.m. *P<0.05, **P<0.01, ***P<0.001 versus normal tissues or NHOK.
- Fig. 2.
The effects of miR-96-5p on proliferation and related molecules in OSCC cells. Tca8113 and Cal-27 cells were transfected with miR-96-5p mimic or inhibitor for 48 h. (A) The level of miR-96-5p was detected by quantitative RT-PCR. (B) Cell proliferation was assessed by a BrdU-ELISA assay. (C) The mRNA expression of CDK4, cyclin D1 and p27 were determined by quantitative RT-PCR. All data are presented as means±s.e.m., n=6. #P<0.05, ##P<0.01, ###P<0.001 versus NC.
- Fig. 3.
The effects of miR-96-5p on the invasion and related molecules expression in OSCC cells. Tca8113 and Cal-27 cells were transfected with miR-96-5p mimic or inhibitor for 48 h. (A) The invasion was assessed by Transwell assay. (B) Total secretions of MMP-2, MMP-9 and TIMP-1 in the culture supernatants were detected by ELISA assays. (C) The mRNA expression of MMP-2, MMP-9 and TIMP-1 were examined by qRT-PCR. All data are presented as means±s.e.m., n=6. #P<0.05, ##P<0.01 versus NC.
- Fig. 4.
Effects of miR-96-5p on the EMT of OSCC cells. Tca8113 and Cal-27 cells were transfected with miR-96-5p mimic or inhibitor for 48 h. The expression of E-cadherin, Vimentin and N-cadherin were detected by western blot assays. All data are presented as mean±s.e.m., n=6. #P<0.05, ##P<0.01 versus NC.
- Fig. 5.
FOXF2 is a direct target of miR-96-5p. Tca8113 and Cal-27 cells were transfected with miR-96-5p mimic or inhibitor for 48 h. (A) Schematic representation of FOXF2 3′UTRs showing putative miRNA target site. (B) The analysis of the relative luciferase activities of FOXF2-WT and FOXF2-MUT. (C) The protein expression of FOXF2 were determined by western blot assay. (D) Quantitative RT-PCR analysis of FOXF2 expression in OSCC tissues (n=40) and adjacent normal tissues (n=40). Transcript levels were normalized to GAPDH expression. (E) Relative FOXF2 expression analyzed via quantitative RT-PCR in five OSCC cell lines normalized to GAPDH (n=6). (F) Pearson's correlation analysis of the relative expression levels of miR-96-5p and the relative FOXF2 mRNA levels in OSCC tissues. All data are presented as means±s.e.m., n=6. ##P<0.01 versus NC; *P<0.05, **P<0.01, ***P<0.001 versus normal tissues or NHOK.
- Fig. 6.
The effects of FOXF2 knockdown on the proliferation, invasion and EMT in OSCC cells. Tca8113 and Cal-27 cells were transfected with si-NC or si-FOXF2 for 48 h. (A) The protein expression of FOXF2 was determined by western blot. (B) Cell proliferation was assessed by a BrdU-ELISA assay. (C) The invasion of OSCC cells was assessed by Transwell assay. (D) Total secretions of MMP-2, MMP-9 and TIMP-1 in the culture supernatants were detected by ELISA assays. (E) The expression of E-cadherin, Vimentin and N-cadherin were detected by western blot assays. All data are presented as means±s.e.m., n=6. #P<0.05, ##P<0.01 versus si-NC.
- Fig. 7.
Introduction of FOXF2 promoted cell proliferation and invasion in miR-96-5p-overexpressing OSCC cells. Tca8113 cells were co-transfected with pcDNA3.1 or pcDNA-FOXF2 with or without miR-96-5p mimic. (A) The protein expression of FOXF2 was determined by western blot assay. (B) Cell proliferation was assessed by a BrdU-ELISA assay. (C) The expression of CDK4, cyclin D1 and p27 were determined by quantitative RT-PCR, respectively. (D) The invasion of OSCC cells was assessed by Transwell assay. (E) Total secretions of MMP-2, MMP-9 and TIMP-1 in the culture supernatants were detected by ELISA assays. (F) The expression of E-cadherin, Vimentin and N-cadherin were detected by western blot assays. All data are presented as means±s.e.m., n=6. *P<0.05, **P<0.01 versus NC; #P<0.05, ##P<0.01 versus miR-96-5p mimic+pcDNA3.1.
Article Navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Biology Open and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Future Leader Review - Cardiac myosin super relaxation
A new Future Leader Review by Manuel Schmid and Christopher Toepfer discusses the rapidly-expanding field of myosin super relaxation in the context of cardiovascular disease. Read the full Review and their accompanying interview.
Find out more about our Future Leader Reviews – they are an exclusive opportunity for early-career researchers who want to establish themselves in their field.
An interview with Roberta Azzarelli
In an interview, first author Roberta Azzarelli discusses her 3D model of glioblastoma and shares her thoughts on how to improve the professional lives of early-career researchers: formal mentorship programmes, a clearly structured career path and taking part in initiatives such as the Node Network.
News from our sister journals
Development continues to run a successful new webinar series, Development presents…, while Journal of Cell Science has recently welcomed Esperanza Agullo-Pascual as FocalPlane’s new Community Manager. Journal of Experimental Biology’s new special issue highlights the role of comparative biology in tackling climate change and Liz Patton, the new Editor-in-Chief of Disease Models & Mechanisms, sets out her visions and priorities.